SCI Science Perspectives

by American Spinal Injury Association

The American Spinal Injury Association (ASIA) brings you SCI Science Perspectives. The podcast is built around two-part dialogues with spinal cord injury (SCI) professionals regarding their emerging scientific work spanning the full spectrum of SCI research, from discovery to clinical application. The SCI Science Perspectives podcast disseminates the latest-and-greatest scientific work in the SCI field via a conversation with ...   ...  Read more

Podcast episodes

  • Community EP028 - SpineX's Neuromodulation for Incontinence with Dr. Parag Gad

    Community EP028 - SpineX's Neuromodulation for Incontinence with Dr. Parag Gad

    Join us this episode for a conversation with Dr. Parag Gad, co-founder and CEO of SpineX, for a conversation about the Spinal Cord Neuromodulator by SpineX and Scone to Treat Neurogenic Bladder, or the SCONE “CONTINENCE” Clinical trial (https://www.clinicaltrials.gov/study/NCT05301335). Dr. Gad talks gives a brief history on SpineX, the scientific inspiration for the current neuromodulation trial targeting incontinence, and visions for the company's future commercial targets. This episode on a neuromodulatory device targeting urinary function was recorded in collaboration with our friends at Bladder Buzz, (in our opinion) the podcast on neurogenic bladder that "brings together physicians, researchers, and individuals living with neurogenic bladder" (https://bladderbuzzpodcast.buzzsprout.com/). We hope you enjoy this collab episode with Dr. Gad from SpineX.

  • Scholarly EP027 - SpineX's Neuromodulation for Incontinence with Dr. Parag Gad

    Scholarly EP027 - SpineX's Neuromodulation for Incontinence with Dr. Parag Gad

    Join us this episode for a conversation with Dr. Parag Gad, co-founder and CEO of SpineX, for a conversation about the Spinal Cord Neuromodulator by SpineX and Scone to Treat Neurogenic Bladder, or the SCONE “CONTINENCE” Clinical trial (https://www.clinicaltrials.gov/study/NCT05301335). Dr. Gad talks gives a brief history on SpineX, the scientific inspiration for the current neuromodulation trial targeting incontinence, and visions for the company's future commercial targets. This episode on a neuromodulatory device targeting urinary function was recorded in collaboration with our friends at Bladder Buzz, (in our opinion) the podcast on neurogenic bladder that "brings together physicians, researchers, and individuals living with neurogenic bladder" (https://bladderbuzzpodcast.buzzsprout.com/). We hope you enjoy this collab episode with Dr. Gad from SpineX.

  • Community EP026 - Clinical Autonomics and Sleep with Dr. Gino Panza

    Community EP026 - Clinical Autonomics and Sleep with Dr. Gino Panza

    Join us this episode for a conversation with Dr. Gino Panza for a conversation about the interaction of autonomic dysfunction, the brain, and sleep. Dr. Panza talks us through their recent review paper (https://doi.org/10.1016/j.apmr.2023.08.006) that shines a clinical lens on the interaction of three topics that are complicated by themselves and that complexify after spinal cord injury (SCI). We trust you'll enjoy this conversation about the nonobvious yet meaningful ways that SCI impacts autonomic function and the brain in a manner relevant to sleep, with Dr. Gino Panza.

  • Scholarly EP025 - Clinical Autonomics and Sleep with Dr. Gino Panza

    Scholarly EP025 - Clinical Autonomics and Sleep with Dr. Gino Panza

    Join us this episode for a conversation with Dr. Gino Panza for a conversation about the interaction of autonomics, the brain, and sleep. Dr. Panza talks us through their recent review paper (https://doi.org/10.1016/j.apmr.2023.08.006) that shines a clinical lens on the interaction of three topics that are complicated by themselves and that complexify after spinal cord injury (SCI). We trust you'll enjoy this conversation about the nonobvious yet meaningful ways that SCI impacts autonomic function and the brain in a manner relevant to sleep, with Dr. Gino Panza.

  • Community EP024 - Past, Present, and Future of Riluzole in Acute SCI with Dr. Michael Fehlings

    Community EP024 - Past, Present, and Future of Riluzole in Acute SCI with Dr. Michael Fehlings

    Join us this episode for a conversation with Dr. Michael Fehlings, the most cited neurosurgeon ever on the topic of spinal cord injury (https://doi.org/10.1038/s41393-021-00691-9), for a conversation about the pharmaceutical agent riluzole for the treatment of acute spinal cord injury (SCI). Dr. Fehlings walks us through the past, present, and future of this drug that has proven efficacy in other neurological conditions and that might serve an important role in initial phases of treating SCI. We trust you'll enjoy this conversation about riluzole from the source of a principal investigator physician-scientist studying it from its inauguration in SCI.